be important for the determination of variant pathogenicity. Whereas variants in the A-band region are predominantly associated with cardiomyopathies, variants in the C-terminal region are preferentially mutated in skeletal muscle disorders [1] [2] [3] . The variant locates in the Nterminal region of TTN where numerous variants including LoF variants are found in the general population [2] . Based on these results, we determined that the impact of TTN p. T587Hfr11Ter variant on the patient's phenotype was highly unlikely.
The patient carried variants in two members of the voltage-gated sodium channels: p. R604C in SCN1A, encoding Nav1.1, and p. R838Q in SCN11A, encoding Nav1.9. Both variants replaced the arginine residues that are conserved among SCN1A and SCN11A between species (Fig. S2. A) . However, these residues showed different degrees of evolutionary conservation when compared to other members of this protein family. The p. R604 residue in SCN1A was only partially conserved. Furthermore, there was no homology of this region containing p. R604C in SCN1A with two other members (Fig. S2. B) . In contrast, p. R838 residue in SCN11A was completely conserved among all nine members of the protein family ( Fig. S2. B) . We then analyzed whether other sodium channels where variants replacing amino acid residues equivalent to SCN1A p. R604 and SCN11A p. R838 residues were pathogenic or associated with human diseases. Results were negative for SCN1A p. R604 residue, whereas three different variants in SCN5A changing the arginine at position 965 equivalent to p. R838 residue in SCN11A are known to be associated with various cardiac diseases. Disease associated SCN11A were reviewed [4] [5] [6] [7] [8] [9] [10] 
